We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Debopam Samanta

Debopam Samanta MD

Associate Professor of Pediatrics and Chief of Child Neurology (Interim), Arkansas Children Hospital (ACH) and University of Arkansas for Medical Sciences (UAMS), Little Rock, AR

Debopam Samanta, MD, is a tenured Associate Professor of Pediatrics and Chief of Child Neurology (Interim) at the Arkansas Children Hospital (ACH) and University of Arkansas for Medical Sciences (UAMS) in Little Rock, AR. Dr. Samanta earned his medical degree with Honors (2004) from Calcutta University and his post-graduate degree in Pediatrics (2007) from Delhi University in India. He pursued his residency training in Pediatric Neurology at the University of Virginia Medical Center (2008-2013), where he received highest academic achievement award in 2011 by the Neurology department. He completed his Clinical Neurophysiology training in UAMS (2013-2014). He is on faculty at the UAMS/ACH for last 6 years, where he is the medical director of tuberous sclerosis clinic, neurometabolic/neurogenetic clinic, and clinical neurophysiology laboratory. He also serves as the interim director of the Epilepsy Monitoring unit and the Division of Child Neurology.

Dr. Samanta has a research interest in the treatment of epilepsy and neurogenetics. He has extensively lectured on the medical treatment of intractable epilepsy and has published his papers in esteemed medical journals.  He directs the Pediatric Neuroscience grand round at Arkansas Children hospital and is a reviewer for several academics journals. He is currently certified in four boards with diplomat status in the American Board of Pediatrics, American Board of Neurology with a special qualification in child neurology, American Board of Clinical Neurophysiology, and American Board of Neurology with a special qualification in Epilepsy. Dr. Samanta has been selected as a committee member to the American Clinical Neurophysiology Society (ACNS) and the American Epilepsy Society (AES).

Disclosures

Dr. Debopam Samanta disclosed that he has participated as an investigator in two GW Pharmaceutical-sponsored studies involving Epidiolex. He did not receive any salary support for this participation.